Silo Pharma (SILO) Silo Pharma announced that its AI subsidiary QwikAgents has joined the AMD AI Developer Program to advance its enterprise AI agent platform.Sector: Biotechnology / AI Technology Key Highlights: ā€¢ QwikAgents joins AMD AI Developer Program ā€¢ Gains access to AMD Developer Cloud credits and development tools ā€¢ Will support development of AI agents for research, coding, scheduling, and browser automation ā€¢ Plans to offer AI agents starting at $14/month for individuals, developers, and small businesses ā€¢ This is a side venture ā€” Siloā€™s main focus remains clinical-stage biopharma (PTSD, fibromyalgia, Alzheimerā€™s programs) Note: Silo completed a 1-for-15 reverse split last month to maintain Nasdaq compliance. This program acceptance provides tooling access but is not a major revenue event yet. https://www.thinksabio.com/isr/reports/SILO